PE-PEG/LEH can reduce its interactions with plasma expanders indexed through viscosity measurements

被引:2
作者
Chung, TW [1 ]
Huang, YY
Wu, CI
机构
[1] Chung Yuan Christian Univ, Dept Biomed Engn, Chungli 32023, Taiwan
[2] Natl Taiwan Univ, Coll Med, Ctr Biomed Engn, Taipei, Taiwan
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY | 1999年 / 27卷 / 03期
关键词
D O I
10.3109/10731199909117695
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To investigate whether PE-PEG coated LEH (PE-PEG/LEH) can reduce its interaction with different plasma expanders and possibly suspended in those expanders, we measured the viscosity of PE-PEG/LEH suspended in different plasma expanders as an index for the interactions. The results showed that lower viscosity values for PE-PEG/LEH were observed compared with LEH especially in low shear rate regions (e.g., 7.72+/-1.46 cp vs. 14.91+/-1.03 cp for (gamma)over dot = 2.25 sec(-1), respectively). Moreover, the viscosity values for PE-PEG/LEH suspended in fibrinogen suspensions were much less than those of LEH in the same media at low shear rate regions (e.g., 7.72+/-1.59 cp vs. 25.78+/-1.59 cp, (gamma)over dot = 2.25 sec(-1), respectively). Similar results were observed for PE-PEG/LEH suspended in 1.83 % of oxypolygelatin (Gel) suspensions and 1.5 % hydrooxyethyl starch (HES) compared to LEH in the same suspension media. On contrast, PE-PEG/LEH suspended in dextran (Dex) showed that dramatically increasing the viscosity values in low shear rates compared with LEH suspended in the same, media (e.g., 78.87+/-0.56 cp vs. 51.08+/-3.52 cp, (gamma)over dot = 2.25 sec(-1), respectively) were observed. Since only minor interactions with Gel, HES or fibrinogen suspensions were observed, we suggest that PE-PEG/LEH suspended in those media but not in Dex can possibly serve for resuscitation oxygen-carrying fluids.
引用
收藏
页码:215 / 227
页数:13
相关论文
共 18 条
[1]  
BENESCH RE, 1973, ANAL BIOCHEM, V55, P24
[2]   INFLUENCE OF VOLUME REPLACEMENT WITH DIFFERENT HES-SOLUTIONS ON MICROCIRCULATORY BLOOD-FLOW IN CARDIAC-SURGERY [J].
BOLDT, J ;
ZICKMANN, B ;
RAPIN, J ;
HAMMERMANN, H ;
DAPPER, F ;
HEMPELMANN, G .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1994, 38 (05) :432-438
[3]   THE OPTIMUM PROCESS CONDITIONS FOR LIPOSOME PRODUCTION USING AN ORTHOGONAL ARRAY EXPERIMENTATION [J].
CHEN, WK ;
WANG, CH ;
LEE, CJ .
JOURNAL OF THE CHINESE INSTITUTE OF ENGINEERS, 1994, 17 (04) :513-520
[4]   An engineering model to characterize oxygen transfer rates for liposome encapsulated hemoglobin (LEH) [J].
Chung, TW ;
Peng, IH .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1998, 26 (04) :389-398
[5]   Viscosity measurements for LEH suspended in different plasma expanders [J].
Chung, TW ;
Wang, JF .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1997, 25 (04) :393-406
[6]  
GROTTA JC, 1989, STROKE, V20, P317
[7]   THE PURIFICATION AND COMPARATIVE-ANALYSIS OF HEMOGLOBIN FROM ANIMAL BLOODS [J].
LEE, CJ ;
KAN, P ;
CHEN, WK .
BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4) :477-488
[8]   HISTOPATHOLOGIC STUDY FOLLOWING ADMINISTRATION OF LIPOSOME-ENCAPSULATED HEMOGLOBIN IN THE NORMOVOLEMIC RAT [J].
RUDOLPH, AS ;
SPIELBERG, H ;
SPARGO, BJ ;
KOSSOVSKY, N .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (02) :189-196
[9]  
Sakai H, 1998, J BIOMED MATER RES, V40, P66, DOI 10.1002/(SICI)1097-4636(199804)40:1<66::AID-JBM8>3.0.CO
[10]  
2-P